doi:10.3969/j.issn.1673-8640.2013.10.001

[1] World Health Organization. WHO diabetes media centre[EB/OL]. (2013-03-01) [2013-08-10]. http://www.who.int/mediacentre/factsheets/fs312/en/index.html.
[2] American Diabetes Association. Economic costs of diabetes in the U.S. in 2007[J]. Diabetes Care,2008,31(6):1271.
[3] The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus[J]. N Eng J Med,1993,329(14):977-986.
[4] UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)[J]. Lancet,1998,352(9131):837-853.
[5] White NH, Sun W, Cleary PA, et al. Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents[J]. Diabetes,2010,59(5):1244-1253.
[6] Weykamp C, John WG, Mosca A. A review of the challenge in measuring hemoglobin A1c[J]. J Diabetes Sci Technol,2009,3(3):439-445.
[7] Jaisson S, Leroy N, Meurice J, et al. First evaluation of Capillarys 2 Flex Piercing^○R (Sebia) as a new analyzer for HbA1c assay by capillary electrophoresis[J]. Clin Chem lab Med,2012,50(10):1769-1775.
[8] Mallia AK, Hermanson GT, Krohn RI, et al. Preparation and use of a boronic acid affinity support for separation and quantisation of glycosylated haemoglobin[J]. Anal Lett,1981,14:649-661.
[9] John WG, Gray MR, Bates DL, et al. Enzyme immunoassay-a new technique for estimating haemoglobin A1c[J]. Clin Chem,1993,39(4):663-666.
[10] Liu L, Hood S, Wang Y, et al. Direct enzymatic assay for % HbA1c in human whole blood samples[J]. Clin Biochem,2008,41(7-8):576-83.
[11] Greg Miller W, Myers GL, Lou Gantzer M, et al. Roadmap for harmonization of clinical laboratory measurement procedures[J]. Clin Chem,2011,57(8):1108-1117.
[12] Little RR, Rohlfing CL, Wiedmeyer HM, et al. The national glycohemoglobin standardization program: a five-year progress report[J]. Clin Chem,2001,47(11):1985-1992.
[13] Shima K, Endo J, Oimomi M, et al. Interlaboratory differences in GHb measurement in Japan, the fifth report of the GHb standardisation committee, the Japan Diabetes Society[J]. J Jap Diab Soc,1998,41:317-333.
[14] Jeppsson JO, Jerntorp P, Sundkvist G, et al. Measurement of haemoglobin A1c by a new liquid-chromatographic assay: methodology, clinical utility and relation to glucose tolerance evaluated[J]. Clin Chem,1986,32(10):1867-1872.
[15] Jeppsson JO, Kobold U, Barr J, et al. Approved IFCC reference method for the measurement of HbA1c in human blood[J]. Clin Chem Lab Med,2002,40(1):78-89.
[16] Weykamp C, John WG, Mosca A, et al. The IFCC reference measurement system for HbA1c: a 6 year progress report[J]. Clin Chem,2008,54(2):240-248.
[17] Consensus Committee. Consensus statement on the worldwide standardization of the hemoglobin A1c measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine and International Diabetes Federation[J]. Diabetes Care,2007,30(9): 2399-2400.
[18] American Diabetes Association. Standards of medical care in diabetes-2011[J]. Diabetes Care,2011,34(Suppl 1):S11-S61.
[19] American Diabetes Association. Standards of medical care in diabetes-2010[J]. Diabetes Care,2010,33(Suppl 1):S11-S61.
[20] Little RR, Rohlfing CL, Tennill AL, et al. Effects of sample storage conditions on glycated haemoglobin measurement: evaluation of five different high performance liquid chromatography methods[J]. Diabetes Technol Ther,2007,9(1):36-42.
[21] Sacks DB, Arnold M, Bakris GL, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus[J]. Clin Chem,2011,57(6):e1-e47.
[22] Little RR, Rohlfing CL, Sacks DB. Status of hemoglobin HbA1c measurement and goals for improvement: from chaos to order for improving diabetes care[J]. Clin Chem,2011,57(2):205-214.
[23] Lenters-Westra E, Slingerland RJ. Six of eight haemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria[J]. Clin Chem,2010,56(1):44-52.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	LIANG Chaohui, ZHAO Fan, LIU Qianwen. Relationship between macrophage migration inhibitory factor and carotid vascular calcification in elderly patients with type 2 diabetes mellitus [J]. Laboratory Medicine, 2023, 38(5): 460-465.
[2]	DENG Xu, ZHUANG Wenlong, XUE Hui, ZHU Shuqin, LI Ying. Relationship between neutrophil/lymphocyte ratio，fibrinogen and carotid intima-media thickness in type 2 diabetes mellitus patients [J]. Laboratory Medicine, 2023, 38(4): 368-372.
[3]	CHEN Hui, CHEN Guanghui, LIANG Yingliang, WANG Wandang, YIN Zhijun. Screening hub genes and diagnostic analysis of gestational diabetes mellitus based on GEO database [J]. Laboratory Medicine, 2023, 38(3): 276-281.
[4]	ZHENG Zhiyou, LI Xingzhao, XIE Yage. Changes and clinical significance of HbA_1c，NT-proBNP，Hcy，SOD and TC levels in patients with diabetes cardiomyopathy [J]. Laboratory Medicine, 2023, 38(3): 282-286.
[5]	KE Qiulei, HUANG Jing, CHEN Aizheng, SONG Yanfeng, SU Xiaofeng. Subgingival flora and the relations between periodontal health indexes and risk of periodontal disease in patients with GDM [J]. Laboratory Medicine, 2023, 38(2): 163-166.
[6]	WU Ying, ZHANG Lihong, GAO Yin. Predictive value of high-density lipoprotein cholesterol on the risk of cerebral ischemic stroke in type 2 diabetes mellitus patients [J]. Laboratory Medicine, 2023, 38(11): 1052-1056.
[7]	QIAN Linyu, LIANG Weifang, TANG Sichen. Determination and clinical significance of NLRP3，CTRP6 and IL-1β in patients with gestational diabetes mellitus [J]. Laboratory Medicine, 2023, 38(10): 936-940.
[8]	CHEN Qian, SHAN Zhiming, SONG Chao, KANG Fengfeng, JIN Jing, LI Weixing. Status of quality management of new laboratories for nucleic acid determination of SARS-CoV-2 in Zhejiang [J]. Laboratory Medicine, 2022, 37(7): 669-673.
[9]	WANG Lingling, REN Chunli. Correlation of MTHFR gene C677T polymorphism and blood lipid levels with GDM [J]. Laboratory Medicine, 2022, 37(6): 543-546.
[10]	ZHANG Xiaoqin, ZHOU Yulan, FU Zhumei, HAN Xuexue, ZHAN Jie. Relationship of mtDNA T16189C mutation and gestational diabetes mellitus [J]. Laboratory Medicine, 2022, 37(5): 413-416.
[11]	QU Yuanqing, ZHAO Fan, YE Ailian, LI Lifeng, ZHAO Haitao, LI Huizhen, LIANG Zhuohui, LI Liang. Relationship between plasma omentin-1 level and metabolic clearance rate in type 2 diabetes mellitus patients [J]. Laboratory Medicine, 2022, 37(1): 28-31.
[12]	YUE Daoyuan, CHEN Wei, LIAO Qing, YU Weiting, LI Huijun. Establishment and evaluation of Wuhan Glycohemoglobin Harmonization Program [J]. Laboratory Medicine, 2022, 37(1): 78-82.
[13]	LE Jiangman, LI Tianyuan, TAN Meiyu, WANG Yajie, ZHOU Lida, SHU Jie, WU Jiaoxiang, SUN Hanxiao, XUAN Binbin, CAI Xushan, SHENG Huiming. Correlation of gestational diabetes mellitus with plasma TMAO [J]. Laboratory Medicine, 2021, 36(8): 795-799.
[14]	WANG Yu, ZHANG Wenwen, LIU Meiling, LIU Xiaojuan. Relationship between AFP,free-βHCG,uE3 and GDM in the second trimester of pregnancy [J]. Laboratory Medicine, 2021, 36(8): 828-832.
[15]	WANG Wei, WANG Lei, WANG Beili, ZHOU Fangfang, HU Jun, WU Pei, YIN Fen, YUAN Kaiying, HOU Yumin, DIAO Duanqin, LI Guoying, CHEN Min, GAO Yuhong. Establishment and preliminary evaluation of HbA_1c determination harmonization plan of Xuhui District of Shanghai [J]. Laboratory Medicine, 2021, 36(5): 549-553.